The whole exome sequencing (WES) revealed several KRAS mutations, which are considered to be a potential diagnosis for CCA [41–43]. KRAS mutations were found more often in patients with eCCA than iCCA [42]. Here, KRAS is linked to cholangiocarcinoma.